Biphasic and region-specific MAO-B response to aging in normal human brain

Neurobiology of Aging

Volumn 18, Issue 5, 1997, Pages 497-507

  Saura, J ^a   Andres N ^a   Andrade, C ^a   Ojuel, J ^a   Eriksson, K ^a   Mahy, N ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Aging human brain; MAO A; MAO B

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

AGING; ARTICLE; AUTORADIOGRAPHY; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SENILE PLAQUE; SEX DIFFERENCE; SUBSTANTIA NIGRA; TEMPORAL CORTEX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; AUTORADIOGRAPHY; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PICOLINIC ACIDS; SEX CHARACTERISTICS; THIAZOLES;

EID: 0030696899     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00113-9     Document Type: Article

References (66)

1. Adolfsson R., Gottfries C. G., Oreland L., Wiberg A., Winbland B. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci. 27:1980;1029-1034.
2. Bach A. W. J., Lan N. C., Johnson D. L., Abell C. W., Bembenek M. E., Kwan S. E., Seeburg P., Shih J. cDNA cloning of human liver monoamine oxidase A and B Molecular basis of differences in enzymatic properties . Proc. Natl. Acad. Sci. USA. 85:1988;4934-4938.
3. Bevan Jones A. B., Pare C. M. B., Nicholson W. J., Price K., Stacey R. S. Brain amine concentrations after monoamine oxidase inhibitor administration. Br. Med. J. 1:1972;17-19.
4. Bogdanovic N., Morris J. H. Diagnostic criteria for Alzheimer's disease in multi-centre brain banking. Cruz-Sanchez F. F., Ravid R., Cuzner M. L. Neuropathological diagnostic criteria for brain banking. 1995;20-29 IOS Press, Amsterdam.
5. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Brody H. An examination of cerebral cortex and brainstem aging. Terry R. D., Gershon S. Neurobiology of Aging. 1976;177-181 Raven Press, New York.
7. Campi N., Todeschini G. P., Scarzella L. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia. Clin. Ther. 12:1990;306-314.
8. 3H]Ro19-6327 A reversible ligand and affinity labelling probe for monoamine oxidase-B . Eur. J. Pharmacol. 162:1989;457-465.
9. Cesura A. M., Pletscher A. The new generation of monoamine oxidase inhibitors. Prog. Drug. Res. 38:1992;171-297.
10. Chan Palay V., Höchli M., Jentsch B., Leonard B., Zetzsche T. Raphe serotonin neurons in the human brain stem in normal controls and patients with senile dementia of Alzheimer type and Parkinson's disease Relationship to monoamine oxidase enzyme localization . Dementia. 3:1992;253-269.
11. Cohen G. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv. Neurol. 45:1986;119-125.
12. Damier P., Kastner A., Agid Y., Hirsch E. C. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease? Neurology. 46:1996;1262-1269.
13. David J.-P., Fallet-Bianco C., Vermersch P., Frigard B., Di Menza C., Delacourte A. Vieillissement cérébral normal Étude de la réaction gliale . CR Acad. Sci. Paris (III). 317:1994;749-753.
14. Dysken M. W., Mendels J., LeWitt P., Reisberg B., Pomara N., Wood J., Skare S., Fakouhi J. D., Herting R. L. Milacemide A placebo-controlled study in senile dementia of the Alzheimer type . J. Am. Ger. Soc. 40:1992;503-506.
15. Fowler C. J., Tipton K. F., MacKay A. V. P., Youdim M. B. H. Human platelet monoamine oxidase - A useful enzyme in the study of psychiatric disorders? Neuroscience. 7:1982;1577-1594.
16. Fowler C. J., Wiberg A., Oreland L., Marcusson J., Winblad B. The affect of age on the activity and molecular properties of human brain monoamine oxidase. J. Neural Transm. 49:1980;1-20.
17. Freisleben H. J., Lehr F., Fuchs J. Lifespan of immunosupressed NMRI-mice is increased by deprenyl. J. Neural Transm. 41:(Suppl.):1994;231-236.
18. Fuller R. W., Hemrick-Luecke S. K., Perry K. W. Elevation of epinephrine concentration in rat brain by LY 51641, a selective inhibitor of type A monoamine oxidase. Res. Comm. Chem. Pathol. 32:1981;207-221.
19. Gottfries C. G., Adolfsson R., Aquilonius S. M., Carlsson A., Eckernäs S. A., Nordberg A., Oreland L., Svennerholm L., Wiberg A., Winblad B. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol. Aging. 4:1983;261-271.
20. Gottfries C. G., Oreland L., Wiberg A., Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem. 25:1975;667-673.
21. Khan A., Lee E., Dager S., Hyde T., Taisys V., Avery D., Dunner D. Platelet MAO-B activity in anxiety and depression. Biol. Psychiatry. 21:1986;847-849.
22. Knoll J. The pharmacology of selegiline (-)deprenyl. New aspects. Acta Neurol. Scand. 126:1989;83-91.
23. Knoll J. Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. Biomed. Pharmacother. 49:1995;187-195.
24. Konradi C., Kornhuber J., Froelich L., Fritze J., Heinsen H., Beckmann H., Schulz E., Riederer P. Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique. Neuroscience. 33:1989;383-400.
25. Konradi C., Svoma E., Jellinger K., Riederer P., Denney R., Thibault J. Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post-mortem brain. Neuroscience. 26:1988;791-802.
26. Kornhuber J., Konradi C., Mack-Burkhardt F., Riederer P., Heinsen H., Beckmann H. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Res. 499:1989;81-86.
27. Leung T. K. C., Lai J. C. K., Lim L. The regional distribution of monoamine oxidase activities toward different substrates Effects in rat brain of chronic administration of manganese chloride and of ageing . J. Neurochem. 36:1981;2037-2043.
28. Mahy N. Brain banks and research in neurochemistry. J. Neural Transm. 39:(Suppl.):1993;119-126.
29. Major L. F., Murphy D. L., Lipper S., Gordon E. Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid. J. Neurochem. 32:1979;229-231.
30. Manaye K. F., Mcintire D. D., Mann D. M. A., German D. C. Locus coeruleus cell loss in the aging human brain A non-random process . J. Comp. Neurol. 358:1995;79-87.
31. Mangoni A., Grasi M. P., Frattola L., Piolti R., Bassi S., Motta A., Marcone A., Smirne S. Effects of a MAO-B inhibitor in the treatment of Alzheimer disease. Eur. Neurol. 31:1991;100-107.
32. Martignoni E., Bomo G., Blandini F., Sinforiani E., Merlo P., Nappi G. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. J. Neural Transm. (P-D Sect.). 3:1991;15-25.
33. Mefford I., Roth K., Jurik S., Collman V., McIntire S., Tolbert L., Barchas J. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641 - comparison with other brain amines. Brain Res. 339:1985;342-345.
34. Milgram N. W., Racine R. J., Nellis P., Mendonca A., Ivy G. O. Maintenance of L-deprenyl prolongs life in aged male rats. Life Sci. 47:1990;415-420.
35. Moll G., Moll R., Riederer P., Gsell W., Heinsen H., Denney R. M. Immunofluoescence cytochemistry of thin frozen sections of human substantia nigra for staining of monoamine oxidase A and monoamine oxidase B a pilot study . J. Neural Transm. 32:(Suppl.):1990;67-77.
36. Monteverde A., Gnemmi P., Rossi F., Finali G. C. Selegiline in the treatment of mild to moderate Alzheimer-type dementia. Clin. Ther. 12:1990;315-322.
37. Morgan D. G., May P. C., Finch C. E. Dopamine ans serotonin systems in human and rodent brain Effects of age and neurodegenerative disease . J. Am. Ger. Soc. 35:1987;334-345.
38. Murphy D. L., Wright C., Buchsbaum M., Nichols A., Costa J. L., Wyatt R. J. Platelet and plasma amine oxidase activity in 680 normals Sex and age differences and stability over time . Biochem. Med. 16:1976;264-265.
39. Nakamura S., Kawamata T., Akiguchi I., Kameyama M., Nakamura N., Kimura T. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol. (Berl). 80:1990;319-325.
40. Nakamura S., Kawamata T., Yasuhara O., Akiguchi I., Kimura J., Kimura H., Kimura T. The histochemical demonstration of monoamine oxidase-containing neurons in the human hypothalamus. Neuroscience. 44:1991;457-463.
41. O'Carroll A. M., Bardsley M. E., Tipton K. F. The oxidation of adrenaline and noradrenaline by the two forms of monoamine oxidase from human and rat brain. Neurochem. Int. 8:1986;493-500.
42. Oreland L., Gottfries G. C. Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog. Neuropsychopharmacol. Biol. Psychiatr. 10:1986;533-540.
43. Palmer A. M., Wilcock G. K., Esiri M. M., Francis P. T., Bowen D. M. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res. 401:1987;231-238.
44. Pandey G. N., Fawcett J., Gibbons R., Clark D. C., Davis J. M. Platelet monoamine oxidase in alcoholism. Biol. Psychiatry. 24:1988;15-24.
45. Paterson I. A., Juorio A. V., Berry M. D., Zhu M. Y. Inhibition of monoamine oxidase-B by L-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. J. Pharmacol. Exp. Ther. 258:1991;1019-1026.
46. Piccinin G. L., Finali G., Piccirilli M. Neuropsychological effects of L-deprenyl in Alzheimer's type dementia. Clin. Neuropharmacol. 13:1990;147-163.
47. Pittman R. N., Minneman K. P., Molinoff P. B. Alterations in beta1 and beta2 adrenergic receptor density in the cerebellum of aging rats. J. Neurochem. 35:1980;273-275.
48. Reinikainen K. J., Paljärvi L., Halonen T., Malminen O., Kosma V. M., Laakso M., Riekkinen P. J. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol. Aging. 9:1988;245-252.
49. Riederer P., Youdim M. B. H. Monoamine oxidase activity and monoamine metabolism in brains of Parkinsonian patients treated with L-deprenyl. J Neurochem. 46:1986;1359-1365.
50. Robinson D. S., Davis J. M., Nies A., Colburn R. W., Davis J. N., Bourne H. R., Bunney W. E., Shaw D. M., Coppen A. J. Ageing, monoamines and monoamine oxidase levels. Lancet. i:1975;290-295.
51. Robinson D. S., Davis J. M., Nies A., Ravaris C. L., Sylwester D. Relation to sex and aging to monoamine oxidase activity of human brain, plasma and platelets. Arch. Gen. Psychiatry. 24:1971;536-539.
52. Robinson D. S., Sourkes T. L., Nies A., Harris L. S., Spector S., Bartlett D. L., Kaye I. S. Monoamine metabolism in human brain. Arch. Gen. Psychiatry. 34:1977;89-92.
53. 2 with monoamine oxidase-B sites . J. Neurochem. 61:1993;881-889.
54. Saura J., Bleuel Z., Ulrich J., Mendelowitsch A., Chen K., Shih J. C., Malherbe P., Da Prada M., Richards J. G. Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hibridization histochemistry. Neuroscience. 70:1996;755-774.
55. 3H-Ro19-6327 in vitro Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain . J. Neurosci. 12:1992;1977-1999.
56. Saura J., Luque J. M., Cesura A. M., Da Prada M., Chan Palay V., Huber G., Löffler J., Richards J. G. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience. 62:1994;15-30.
57. Sherif F., Gottfries C. G., Alafuzoff I., Oreland L. Brain γ-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J. Neural Transm. (P-D Sect.). 4:1992;227-240.
58. Sparks D. L., Woeltz V. M., Markesbery W. R. Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease and Pick's disease. Arch. Neurol. 48:1991;718-721.
59. Strolin Benedetti M., Keane P. E. Differential changes in monoamine oxidase A and B activity in the aging rat brain. J. Neurochem. 35:1980;1026-1032.
60. Tariot P. N., Cohen R. M., Sunderland T., Newhouse P. A., Yount D., Mellow A. M., Weintgartner H., Mueller E. A., Murphy D. L. L-Deprenyl in Alzheimer's disease. Arch. Gen. Psychiatry. 44:1987;427-433.
61. Terry R. D., DeTeresa R., Hansen L. A. Neocortical cell counts in normal human aging. Ann. Neurol. 21:1987;530-539.
62. Waldmeier P. C. Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). J. Neural Transm. 23:(Suppl.):1987;55-72.
63. Waldmeier P. C., Feldtrauer J. J., Maître L. Methylhistamine Evidence for selective deamination by MAO-B in the rat brain in vivo . J. Neurochem. 29:1977;785-790.
64. Westlund K. N., Denney R. M., Kochersperger L. M., Rose R. M., Abell C. W. Distinct monoamine oxidase A and B populations in primate brain. Science. 230:1985;181-183.
65. Westlund K. N., Denney R. M., Rose R. M., Abell C. W. Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience. 25:1988;439-456.
66. Young W. F., Lwas E. R., Sharbrough F. W., Weinshilboum R. M. Human monoamine oxidase Lack of brain and platelet correlation . Arch. Gen. Psychiatry. 43:1986;604-609.